2,2',6,6'-tetraisopropyl-4,4'-biphenol lipid microsphere preparations and preparation methods therefor

a technology of tetraisopropyl and lipid microspheres, which is applied in the field of pharmaceutical preparations, can solve the problems of difficult water dissolution of tetraisopropyl-4,4'-biphenol, limited clinical application, and affect the efficacy, so as to improve the therapeutic effect of the drug and improve the absorption

Inactive Publication Date: 2014-12-18
XIAN LIBANG PHARMA
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0041]In this invention, the method for administering the drug is switched from oral administration to intravenous injection which improves drug absorption and increases the therapeutic effect of the drug;
[0042]Detailed experimental results on the anti-epileptic effect of the preparation of this invention can be found in the Examples.

Problems solved by technology

However, biphenol is a highly lipid soluble compound that is difficult to dissolve in water.
Studies have shown that it is difficult to achieve a desired effect by using surfactants such as cyclodextrin, Tween 80, Vc or DMSO to assist or increase its dissolution and, thereby, its efficacy is affected and its clinical application becomes limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2,2',6,6'-tetraisopropyl-4,4'-biphenol lipid microsphere preparations and preparation methods therefor

Examples

Experimental program
Comparison scheme
Effect test

example 1

1% Biphenol Lipid Microsphere Preparation

[0046]

Drugs and ExcipientsAmount (g)Biphenol10.0Soybean oil (Injection-grade)100Egg lecithin12Vitamin E10Glycerin25EDTA5Injection-grade waterMake up to 1000 ml

Preparation Method

[0047]1) 12 g of egg lecithin was completely dissolved in 100 g of injection-grade oil under a nitrogen atmosphere and in a 70° C. water bath. 10 g of biphenol and 10 g of vitamin E were then added and nitrogen gas was fed in for protection before being dissolved, with heat and stirring, to obtain an oil phase.

[0048]2) 20 g of glycerin and 5 g of EDTA were dissolved, with stirring, in the injection-grade water to obtained an aqueous phase.

[0049]3) The oil phase was added slowly to the aqueous phase while sheared under nitrogen (10000 r, 5 min) to obtain a preliminary emulsion which was then adjusted to around pH 8.0 with sodium hydroxide.

[0050]4) The preliminary emulsion was homogenized with a high-pressure homogenizer and filtered with a microporous membrane filter be...

example 2

0.1% Biphenol Lipid Microsphere Preparation

[0051]

Drugs and ExcipientsAmount (g)Biphenol1.0Sea buckthorn oil (Injection-100grade)Hydrogenated Lecithin12Ascorbic acid10Glycerin25EDTA5Injection-grade waterMake up to 1000 ml

Preparation Method

[0052]1) 12 g of hydrogenated lecithin was completely dissolved in 100 g of injection-grade oil under a nitrogen atmosphere and in a 70° C. water bath. 1 g of biphenol was then added and nitrogen gas was fed in for protection before being dissolved, with heat and stirring, to obtain an oil phase.

[0053]2) 25 g of glycerin, 10 g ascorbic acid and 5 g of EDTA were dissolved, with stirring, in the injection-grade water to obtain the aqueous phase.

[0054]3) The oil phase was added slowly to the aqueous phase while sheared under nitrogen (10000 r, 5 min) to obtain a preliminary emulsion which was then adjusted to around pH 8.0 with sodium hydroxide.

[0055]4) The preliminary emulsion was homogenized with a high-pressure homogenizer and filtered with a microp...

example 3

3% Biphenol Lipid Microsphere Preparation

[0056]

Drugs and ExcipientsAmount (g)Biphenol30Injection-grade Medium-chain100triglyceride oilSoy lecithin12Sodium bisulfite10Glycerin25EDTA5Injection-grade waterMake up to 1000 ml

Preparation Method

[0057]1) 12 g of soy lecithin was completely dissolved in 100 g of injection-grade oil under a nitrogen atmosphere and in a 70° C. water bath. 30 g of biphenol was then added and nitrogen gas was fed in for protection before being dissolved, with heat and stirring, to obtain an oil phase.

[0058]2) 25 g of glycerin, 10 g of sodium bisulfite and 5 g of EDTA were dissolved, with stirring, in the injection-grade water to obtained an aqueous phase.

[0059]3) The oil phase was added slowly to the aqueous phase while sheared under nitrogen (10000 r, 5 min) to obtain a preliminary emulsion which was then adjusted to around pH 8.0 with sodium hydroxide.

[0060]4) The preliminary emulsion was homogenized with a high-pressure homogenizer and filtered with a micropo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
pressureaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

This invention relates to a 2,2′,6,6′-tetraisopropyl-4,4′-biphenol lipid microsphere preparation having 2,2′,6,6′-tetraisopropyl-4,4′-biphenol as its active ingredient and formed into said lipid microsphere preparation with common medically used injection-grade oil, emulsifier, and injection-grade water.

Description

FIELD OF THE INVENTION[0001]This invention relates to 2,2′,6,6′-tetraisopropyl-4,4′-biphenol lipid microsphere preparations and the preparation methods therefor, in the field of pharmaceutical preparations.BACKGROUND OF THE INVENTION[0002]2,2′,6,6′-tetraisopropyl-4,4′-biphenol (hereinafter referred to as biphenol) is an anti-epileptic compound newly developed (Chinese patent CN 101804043A, Uses of biphenol and its derivatives in drugs for the treatment of epilepsy) for treating many epileptic symptoms such as generalized tonic-clonic seizures (grand mal), absence seizures (petit mal), simple partial seizures, complex partial seizures (psychomotor seizures), autonomic seizures (periodic seizures) and others. Experimental studies have shown that biphenol has a strong affinity towards GABA receptors and is a GABA agonist, while it is an antagonist for NMDA receptors for regulating the Ca2+ influx in Ca2+ channels. Biphenol also offers protection against the excitotoxic effect induced b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/16A61K31/05
CPCA61K31/05A61K9/16A61K9/0019A61K47/44A61K47/12A61K47/24A61K9/1075A61P25/08A61K9/5015A61K9/5089A61K47/02A61K47/10A61K47/22
Inventor WANG, RUTAOCHEN, TAOGUO, SHUPANHU, HUIJINGAN, LONGWANG, WEIJIAO
Owner XIAN LIBANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap